ArticleOncology letters2016

Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation.

Dai-Ying Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.